With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The Democratic Republic of the Congo's (DRC's) health ministry revised its tally of the ongoing Ebola outbreak today, noting three more cases and one additional fatality. Officials have now reported 344 cases and 202 deaths in an outbreak that begin in North Kivu and Ituri provinces in August.
In children, flu vaccine effectiveness declines over 9 months following immunization, according to a study in Hong Kong that took place over five flu seasons. A team based at the University of Hong Kong reported its findings on Nov 12 in The Lancet Respiratory Medicine.
Saudi Arabia's Ministry of Health (MOH) today reported a new MERS case for epidemiologic week 46 in the Qassim region.
The patient is a 67-year-old man hospitalized for his infection with MERS-CoV (Middle East respiratory syndrome coronavirus). He had no contact with camels, and the source of his infection is listed as "primary, community acquired."
In the latest global polio developments, Pakistan reported two new wild poliovirus type 1 cases and three African countries reported seven more vaccine-derived polio cases in their outbreaks, according to today's weekly update from the Global Polio Eradication Initiative (GPEI).
Saudi Arabia reported two more MERS-CoV cases, according to an update to its week 44 epidemiologic report today.
Neither of the patients had contact with camels, a factor known to raise the risk of contracting MERS-CoV (Middle East respiratory syndrome coronavirus). One patient is a 62-year-old man from the city of Omluj in Tabuk region in the northwest, and the other is a 53-year-old man from Riyadh in the central part of the country.
Save for the 2009-10 pandemic, the season was the worst in recent years.
An investigation into 40 variant H3N2 (H3N2v) influenza cases in people exposed to pigs at three agriculture fairs in Maryland in September 2017 found that 30 (75%) occurred in people at high risk for flu complications. Researchers from the US Centers for Disease Control and Prevention and Maryland described their findings today in Morbidity and Mortality Weekly Report (MMWR).
Today the US Food and Drug Administration (FDA) approved Xofluza (baloxavir marboxil) for the treatment of flu in patients ages 12 years and older who have been symptomatic for no more than 48 hours.
Xofluza is the first novel flu treatment approved by the FDA in nearly 20 years; the FDA approved the neuraminidase inhibitors oseltamivir and zanamivir in 1999.
The CDC started its reporting for the new flu season last week, and so far most of the United States is experiencing sporadic flu detections.
The Centers for Disease Control and Prevention (CDC) today announced a new outbreak of multidrug-resistant Salmonella Infantis infections tied to raw chicken products.
